The RWE Navigator is an output of GetReal work package 1 (WP1), which in turn summarises and integrates the outputs of all other work packages of the GetReal project. The work on this website has been funded through IMI GetReal. It is currently a beta website. The site was launched on the 8th March 2017
For more information watch the launch Webinar for the RWE Navigator, held in March 2017, and hosted by Vital Transformation (click here).
Sarah Garner (Associate Director of Science Policy and Research at NICE), Rob Thwaites (Senior Director at Takeda) and Páll Jónsson (Senior Scientific Adviser, NICE) provided oversight on the project. Mike Chambers (Director, MC Healthcare Evaluation) was instrumental in developing the overall concept of the site and drafted text for individual pages. Heather Stegenga (Senior Analyst at NICE) coordinated and developed webpages and content; this included arranging content to be drafted by others and editing this text, as well as drafting original text. Adeeb Ahsan (Project Manager at NICE) provided project management support. Mike Groves (Project Manager at NICE) and Maciej Czachorowski (Technical Analyst at NICE) were involved in background work leading to the development of the RWE Navigator. Catharine Baden-Daintree (NICE editorial team) provided editorial input on much of the content of the site. Chris Chinn (Head of Real World Investigations at Sanofi) led in designing the structure and content of the ‘Clarify the issues’ section.
The site was developed and designed by the NICE digital services team, led by Tom Proudman with contributions from Mike Howarth, John Williams and John Holland.
Various members of GetReal drafted content for their specialist topic areas and also made general suggestions for site improvements. Content contributors are listed at the relevant pages of the site.
A review of the content of the RWE Navigator was undertaken in late 2019 by Mike Chambers (Director, MC Healthcare Evaluation), Emily Leckenby (Technical Analyst, NICE) and Dalia Dawoud (Scientific Advisor, NICE), with oversight provided by Páll Jónsson (Associate Director, NICE).